Table 1.
Active | Borderline | |
Number of patients | 26 (62%) | 16 (38%) |
Age (years) | 37 (15) (range 14–77) | 40 (13) (range 20–61) |
Men/women | 16/10 | 9/7 |
Familial history of dilated cardiomyopathy | 0 (0%) | 3 (19%)* |
Peripartum onset | 2 (8%) | 2 (12.%) |
Personal history of autoimmune disease | 2 (8%) | 3 (19%) |
Flu like syndrome | 10 (38%) | 6 (37.%) |
Clinical features at onset | ||
CHF | 8 (31%) | 11 (68.7%) |
AMI-like | 8 (31%) | 3 (18.7%) |
VT | 7 (27%) | 2 (12.5%) |
Cardiogenic shock | 3 (11%) | 0 (0%) |
NYHA functional class at onset | 2.4 (1.3) | 2.2 (1.2) |
Follow up | ||
NYHA functional class | 1.3 (0.6) | 1.1 (0.4) |
Death/CT | 4 (15%) | 2 (12.5%) |
Data are mean (SD).
*p = 0.02.
AMI, acute myocardial infarction; CHF, congestive heart failure; CT, cardiac transplantation; NYHA, New York Heart Association; VT, symptomatic ventricular tachycardia.